Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Chemours stock (CC)

Buy Chemours stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Chemours is a specialty chemicals business based in the US. Chemours shares (CC) are listed on the NYSE and all prices are listed in US Dollars. Chemours employs 6,200 staff and has a trailing 12-month revenue of around $5.8 billion.

Our top picks for where to buy Chemours stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Chemours stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – CC. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Chemours stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Not rated yet
Stocks, ETFs
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Cash App
Finder Score: 3 / 5: ★★★★★
Cash App
Stocks, ETFs, Cryptocurrency
Buy and sell over 1,800 stocks and ETFs commission-free and for as little as $1.
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Chemours stock price (NYSE: CC)

Use our graph to track the performance of CC stocks over time.

Chemours shares at a glance

Information last updated 2024-07-11.
Latest market close$24.57
52-week range$14.97 - $37.72
50-day moving average $25.32
200-day moving average $27.14
Wall St. target price$30.67
PE ratio N/A
Dividend yield $1 (4.32%)
Earnings per share (TTM) $-2.22

Is it a good time to buy Chemours stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Chemours price performance over time

Historical closes compared with the close of $24.57 from 2024-07-17

1 week (2024-07-11) 1.28%
1 month (2024-06-18) 3.02%
3 months (2024-04-18) -7.21%
6 months (2024-01-18) -16.29%
1 year (2023-07-18) -36.30%
2 years (2022-07-18) -22.93%
3 years (2021-07-16) 31.5989
5 years (2019-07-18) 44.62%

Is Chemours stock undervalued or overvalued?

Valuing Chemours stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Chemours's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Chemours's PEG ratio

Chemours's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6685. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Chemours's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Chemours's EBITDA

Chemours's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $869 million.

The EBITDA is a measure of a Chemours's overall financial performance and is widely used to measure a its profitability.

Chemours financials

Revenue TTM $5.8 billion
Operating margin TTM 8.52%
Gross profit TTM $1.6 billion
Return on assets TTM 4.57%
Return on equity TTM -33.3%
Profit margin -5.67%
Book value $5.05
Market Capitalization $3.4 billion

TTM: trailing 12 months

Chemours share dividends


Dividend payout ratio: 42.37% of net profits

Recently Chemours has paid out, on average, around 42.37% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.32% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Chemours shareholders could enjoy a 4.32% return on their shares, in the form of dividend payments. In Chemours's case, that would currently equate to about $1 per share.

While Chemours's payout ratio might seem fairly standard, it's worth remembering that Chemours may be investing much of the rest of its net profits in future growth.

Chemours's most recent dividend payout was on 13 June 2024. The latest dividend was paid out to all shareholders who bought their shares by 13 May 2024 (the "ex-dividend date").

Chemours share price volatility

Over the last 12 months, Chemours's shares have ranged in value from as little as $14.9685 up to $37.7246. A popular way to gauge a stock's volatility is its "beta".

CC.US volatility(beta: 1.79)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Chemours's is 1.794. This would suggest that Chemours's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Chemours overview

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for electronics, communications, transportation, wire and cable, energy, oil and gas, and medical, and other applications under the eflon, Viton, Krytox, and Nafion brands. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

Frequently asked questions

What percentage of Chemours is owned by insiders or institutions?
Currently 0.653% of Chemours shares are held by insiders and 77.885% by institutions.
How many people work for Chemours?
Latest data suggests 6,200 work at Chemours.
When does the fiscal year end for Chemours?
Chemours's fiscal year ends in December.
Where is Chemours based?
Chemours's address is: 1007 Market Street, Wilmington, DE, United States, 19801
What is Chemours's ISIN number?
Chemours's international securities identification number is: US1638511089
What is Chemours's CUSIP number?
Chemours's Committee on Uniform Securities Identification Procedures number is: 163851108

More guides on Finder

Ask a question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site